- Home
- NBXG vs ORIC Comparison
NBXG vs ORIC Comparison
Compare NBXG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBXG
- ORIC
- Stock Information
- Founded
- NBXG 2021
- ORIC 2014
- Country
- NBXG United States
- ORIC United States
- Employees
- NBXG N/A
- ORIC N/A
- Industry
- NBXG Trusts Except Educational Religious and Charitable
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- NBXG Finance
- ORIC Health Care
- Exchange
- NBXG Nasdaq
- ORIC Nasdaq
- Market Cap
- NBXG 1.1B
- ORIC 974.1M
- IPO Year
- NBXG N/A
- ORIC 2020
- Fundamental
- Price
- NBXG $15.12
- ORIC $10.78
- Analyst Decision
- NBXG
- ORIC Strong Buy
- Analyst Count
- NBXG 0
- ORIC 10
- Target Price
- NBXG N/A
- ORIC $17.33
- AVG Volume (30 Days)
- NBXG 243.7K
- ORIC 857.5K
- Earning Date
- NBXG 01-01-0001
- ORIC 11-11-2025
- Dividend Yield
- NBXG 10.25%
- ORIC N/A
- EPS Growth
- NBXG N/A
- ORIC N/A
- EPS
- NBXG N/A
- ORIC N/A
- Revenue
- NBXG N/A
- ORIC N/A
- Revenue This Year
- NBXG N/A
- ORIC N/A
- Revenue Next Year
- NBXG N/A
- ORIC N/A
- P/E Ratio
- NBXG N/A
- ORIC N/A
- Revenue Growth
- NBXG N/A
- ORIC N/A
- 52 Week Low
- NBXG $9.31
- ORIC $3.90
- 52 Week High
- NBXG $12.23
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- NBXG 63.82
- ORIC 57.09
- Support Level
- NBXG $14.54
- ORIC $10.36
- Resistance Level
- NBXG $15.24
- ORIC $11.20
- Average True Range (ATR)
- NBXG 0.17
- ORIC 0.48
- MACD
- NBXG 0.03
- ORIC 0.08
- Stochastic Oscillator
- NBXG 82.86
- ORIC 72.39
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.